Document is current
Any future updates will be listed below
-
Authors
Evans, Marc
Evans, William https://orcid.org/0009-0008-6270-961X
Godbeer, Fiona
Edgar, Laurienne
Spaepen, Erik
Davies, Alun Lloyd
-
Funding
Funding for this research was provided by:
The preparation of the manuscript and the journals’ Rapid Service and Open Access fees, were funded by Eli Lilly and Company.
- License Information
-
More Information
Article History
Received: 31 January 2025
Accepted: 28 March 2025
First Online: 18 April 2025
Declarations
:
: Marc Evans and Alun Lloyd Davies report no conflicts of interest for the work under consideration for publication. Erik Spaepen reports receiving consulting fees from Eli Lilly and Company. William Evans, and Fiona Godbeer are employees and minor shareholders of Eli Lilly and Company. Laurienne Edgar is a former employee of Eli Lilly and Company.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The SURMOUNT-1 study received the necessary ethical approvals from all study sites, obtained informed patient consent to participate and was conducted in accordance with the Declaration of Helsinki.
